PRISYM ID Chief Executive announces five new business wins Specialist knowledge, understanding and experience are key to fulfilling the life science and medical device industries’ unique requirements. Read More
PRISYM ID onboards new cloud-based labelling platform within weeks for clinical trial supplies specialist RxSource Discover how PRISYM ID completed the onboarding process in just five weeks… Read More
RxSource Shares Advice on Optimizing Labelling Processes Join industry experts from PRISYM ID and RxSource to explore the key areas to optimizing your labelling and packaging processes. Read More
A Christmas Message From Our CEO Richard Adams Posted on 21st December 2020 by Jack Cowmeadow Like most companies, PRISYM ID’s year was dominated by a word and a disease that few had heard of on the 1st January. Read More
PRISYM 360 Achieves SAP® Certification as Integrated with Cloud Solutions from SAP The latest version of the PRISYM 360 intelligent data import connector now has SAP-certified integration using SAP Cloud Platform Integration Suite. Read More
Global Clinical Trial Supplies Specialist RxSource invests in clinical labeling software to enhance service offering PRISYM 360 SaaS clinical trials solution will help RxSource streamline its operations. Read More
PRISYM 360 Vision Inspection for Medical Device Labels Find out how PRISYM 360 Vision Inspection solution can support your organization’s medical device labeling needs. Read More
PRISYM 360 Vision Inspection for Clinical Trial Labels Find out how PRISYM 360 Vision Inspection solution can support your organization’s clinical trial labeling needs. Read More
Push the Button on Content ‘Mass Change’ Events & Labeling Simplify and Standardize your Approach to Managing Content Changes to Regulated Labels, Multi-page Documents and IFUs. Read More
Labeling Scrutinized – Understanding Label Inspection Processes Medical device and pharmaceutical organizations are constantly looking at ways to avoid labeling errors which are a major reason for FDA product recalls. Read More
